PolyPid Ltd. – Filings and Transcripts

NASDAQ: PYPD
Share price (8/7/26): $4.84
Market cap (8/7/26): $92.4 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 12/31/24 FY 2024

ended 12/31/23 FY 2023

ended 12/31/22 FY 2022

ended 12/31/21 FY 2021

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Registration of securities for employees

Shelf registration

Exempt offering of securities

Shelf registration

Ownership Filter

Missulawin Jonathan

Hazan Dalit Fellous

Barenholz Yechezkel

Stein Robert Benjamin

News Filter

Announces FDA Acceptance of NDA With Priority Review for D-Plex100

Announces Exclusive Partnership With Azurity Pharmaceuticals for the Commercialization of D-Plex₁₀₀ in the U.S. and Canada

Amended and Restated 2012 Share Option Plan

Notice of Annual and Extraordinary General Meeting of Shareholders to Be Held on July 15, 2026

Completes New Drug Application Submission to FDA for D-Plex100

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC